Frequently Asked Questions
The market is segmented based on , By Influenza Type (Seasonal, Zoonotic), Manufacturing Technology (Egg-Based, Cell Culture-Based, Recombinant-Based), Vaccine Type (Quadrivalent Influenza Vaccines, Trivalent Influenza Vaccines, Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines, Live Attenuated Virus Vaccines), Age Group (Pediatric, Adult), End User (Hospitals and Clinics, Research Organizations and Academic Institutes, Others), Dosage Form (Nasal Spray, Intramuscular Injection, Intradermal Shot) – Industry Trends and Forecast to 2029.
.
The Global Flu Vaccines Market size was valued at USD 7.50 USD Billion in 2021.
The Global Flu Vaccines Market is projected to grow at a CAGR of 8.9% during the forecast period of 2022 to 2029.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
